These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 23064919)
41. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis. Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325 [TBL] [Abstract][Full Text] [Related]
42. [Review of the current status of research in steroid contraception]. Vojta M Cesk Gynekol; 1970 Sep; 35(7):431-3. PubMed ID: 4924730 [No Abstract] [Full Text] [Related]
43. Menopausal hormone therapy: a better and safer future. Davey DA Climacteric; 2018 Oct; 21(5):454-461. PubMed ID: 29526116 [TBL] [Abstract][Full Text] [Related]
44. Morphologic changes in the uterus associated with steroid contraceptives and intrauterine contraceptive devices. Ober WB Acta Cytol; 1970 Mar; 14(3):156. PubMed ID: 5265919 [No Abstract] [Full Text] [Related]
45. Oral contraceptives and venous thromboembolism. A case-control study. Lidegaard O; Edström B; Kreiner S Contraception; 1998 May; 57(5):291-301. PubMed ID: 9673836 [TBL] [Abstract][Full Text] [Related]
46. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. Mantha S; Karp R; Raghavan V; Terrin N; Bauer KA; Zwicker JI BMJ; 2012 Aug; 345():e4944. PubMed ID: 22872710 [TBL] [Abstract][Full Text] [Related]
47. Long-term contraceptives. Brown A Best Pract Res Clin Obstet Gynaecol; 2010 Oct; 24(5):617-31. PubMed ID: 20558111 [TBL] [Abstract][Full Text] [Related]
49. [Which contraception for women with increased risk of venous thromboembolism?]. Julen O; Dubuisson JB; Lourenço AG Rev Med Suisse; 2011 Feb; 7(281):351-4, 356. PubMed ID: 21416714 [TBL] [Abstract][Full Text] [Related]
50. Current research in steroid contraception. Tyler ET J Reprod Fertil; 1969 Nov; 20(2):319-30. PubMed ID: 4186798 [No Abstract] [Full Text] [Related]
51. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives. Shulman LP Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825 [TBL] [Abstract][Full Text] [Related]
52. Combined oral contraceptives. A statement by the committee on safety of drugs. Br Med J; 1970 Apr; 2(5703):231-2. PubMed ID: 5443411 [No Abstract] [Full Text] [Related]
53. [Hormone therapy and risk for venous thromboembolism in postmenopausal women]. Lacut K; Oger E Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617 [TBL] [Abstract][Full Text] [Related]
54. [Hormonal contraceptives, peripheral venous insufficiency and the use of a phlebodynamic agent]. Cervantes A; Gorodovsky J; Peña A; Campos J Ginecol Obstet Mex; 1976 Aug; 40(238):113-6. PubMed ID: 786800 [No Abstract] [Full Text] [Related]
55. Hormone therapy. An update on risks and benefits. Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167 [No Abstract] [Full Text] [Related]
56. [Advances in hormonal contraception]. Villanueva Egan LA; Pichardo Cuevas M Ginecol Obstet Mex; 2007 Jan; 75(1):35-42. PubMed ID: 17542267 [TBL] [Abstract][Full Text] [Related]